摘要
目的探讨分析视觉模拟评分法(visual analogue scale,VAS)和16项抑郁症状快速评估量表(brief 16-item quick inventory of depressive symptomatology self-report,QIDS-SR16)对抑郁症患者症状缓解程度评估的一致性。方法本研究为全国多中心横断面调查。纳入2014年9月至2015年4月在全国共11家医院就诊的、经过急性期治疗抑郁症状缓解50%以上的门诊抑郁症患者,采用VAS和QIDS-SR16评估患者本次急性期治疗前后抑郁症状的改善程度,将抑郁症状改善50%以上的患者纳入本研究。分析VAS和QIDSSR16评估抑郁症状缓解程度的一致性,并确定使用VAS判定"完全缓解"的最佳界值分。结果共纳入722例抑郁症患者,VAS评分与QIDS-SR16总分呈负相关(r=-0.626,P<0.05)。VAS评分以7分为界限,即受试者认为总体改善≥70%时,区分完全缓解及有残留症状的约登指数最高。结论 VAS与QIDS-SR16一致性良好,采用VAS衡量抑郁症状改善情况在临床实践中具有可行性。
Objective To explore the consistency of the visual analogue scale（VAS） and the rapid assessment of depressive symptoms（brief 16-item quick inventory of depressive symptomatology self-report）. Method The study was a cross-sectional survey in China. VAS and QIDS-SR16 were used to evaluate the improvement of depressive symptoms before and after the acute stage of treatment, and the patients with depressive symptoms improved more than 50% were included in the study. The consistency of VAS and QIDS-SR16 in assessing the degree of remission of depressive symptoms was analyzed, and the best cut-off value of ＂complete remission＂ determined by VAS was determined. Result A total of 722 patients with depression were included in this analysis, and the VAS score was negatively correlated with the total score of QIDS-SR16 scale. The total score of the visual analogue scale was divided into 7 points, that is, when the subjects thought the overall improvement was 70% or more, the Youden index, which was divided into complete remission and residual symptoms, was the highest. Conclusion The visual analogue scale is in good agreement with the rapid assessment scale of depressive symptoms. It is feasible to use the visual analogue scale to measure the improvement of depressive symptoms in clinical practice.
作者
杨蕊
朱雪泉
肖乐
王巍巍
丰雷
YANG Rui;ZHU Xue-quan;XIAO Le;WANG Wei-wei;FENG Lei(National Clinical Research Center for Mental Diseases,Capital Medical University Beijing Anding Hospital Beijing 100088,China;Capital Medical University Affiliated Depression Treatment Center,Ward 12,Beiking 100088,China;Psychiatric Diagnosis and Treatment of Beo＇ing City Key Laboratory,Beijing 100088,China)
出处
《中国医刊》
CAS
2018年第8期918-921,共4页
Chinese Journal of Medicine
基金
国家重点研发计划(2016YFC1307200)
北京市医院管理局临床医学发展专项经费资助(ZYLX201607)
北京市医院管理局"登峰"计划专项经费资助(DFL20151801)
